About Loxo Oncology at Lilly
Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients.
Loxo@Lilly is a global organization with team members in Boulder, Colorado; Indianapolis, Indiana; New York City, New York; San Diego, California; South San Francisco, California; Stamford, Connecticut; and Madrid, Spain.
Facts about Loxo Oncology at Lilly
Facts about Loxo Oncology at Lilly
- Founding: 2013
- Industry : Pharma
Here you will find Loxo Oncology at Lilly
Last viewed contents
Cancer drug aids the regeneration of spinal cord injuries - Taxol stabilizes growing nerve cells and reduces the barrier-function of scar tissue
Phoma_exigua_var._foveata
APEPTICO Initiates Phase I Trial with AP301 in Pulmonary Oedema
Genmab and PDL Biopharma sign purchase agreement for antibody manufacturing facility
Locate Bio Ltd. - Beeston, Nottingham, United Kingdom
Chimerix, Inc. - Durham, USA
Biological_neural_network
Merck KGaA to Sell its Crop BioScience Business To Novozymes for USD 275 Million
Genelabs Drug Discovery Team Advances Compounds Against the Hepatitis C Virus In Preclinical Development
Lipomed AG - Arlesheim, Switzerland
Phytophthora_infestans
